Human Elisa Laboratories manufactures the bms2212 pd-l1 human elisa kit reagents distributed by Genprice. The Bms2212 Pd-L1 Human Elisa Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Human elisa. Other Bms2212 products are available in stock. Specificity: Bms2212 Category: Pd-L1 Group: Human Elisa
PD-L1 Protein |
|
Abbexa |
-
EUR 1930.80
-
EUR 393.60
-
EUR 276.00
|
|
|
|
PD-L1 (CD274) |
|
BPS Bioscience |
100 µg |
EUR 320 |
|
Description: Human secreted Programmed Cell Death 1 Ligand 1 (PD-L1) protein, also known as CD274, PDCD1L1, and B7 homolog 1 (B7-H1), GenBank Accession No. NM_014143, a.a. 19-239, expressed in an E. coli expression system. MW = 25 kDa. |
PD-L1 (CD274) |
|
BPS Bioscience |
1 mg |
EUR 2720 |
|
Description: Human secreted Programmed Cell Death 1 Ligand 1 (PD-L1) protein, also known as CD274, PDCD1L1, and B7 homolog 1 (B7-H1), GenBank Accession No. NM_014143, a.a. 19-239, expressed in an E. coli expression system. MW = 25 kDa. |
PD-L1 Antibody |
|
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
PD-L1 Antibody |
|
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
PD-L1 Peptide |
|
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) PD-L1 peptide |
PD-L1 Antibody |
|
SAB |
100ul |
EUR 399.6 |
Human Elisa information
BMS-794833 |
|
B1438-50 |
ApexBio |
50 mg |
EUR 999.6 |
|
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
BMS-794833 |
|
B1438-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
|
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
BMS-378806 |
|
B1533-10 |
ApexBio |
10 mg |
EUR 366 |
|
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
BMS-378806 |
|
B1533-100 |
ApexBio |
100 mg |
EUR 1423.2 |
|
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
BMS-378806 |
|
B1533-5 |
ApexBio |
5 mg |
EUR 226.8 |
|
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
BMS-378806 |
|
B1533-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 282 |
|
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
BMS-378806 |
|
B1533-50 |
ApexBio |
50 mg |
EUR 1005.6 |
|
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
BMS-817378 |
|
B5862-10 |
ApexBio |
10 mg |
EUR 373.2 |
|
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
BMS-817378 |
|
B5862-5 |
ApexBio |
5 mg |
EUR 226.8 |
|
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
BMS-817378 |
|
B5862-50 |
ApexBio |
50 mg |
EUR 999.6 |
|
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
Welcome to our blog!